Molecular testing for hereditary retinal disease as part of clinical care

Archives of Ophthalmology

Volumn 125, Issue 2, 2007, Pages 252-258

  Downs, Katy ^a,b   Zacks, David N ^a   Caruso, Rafael ^c   Karoukis, Athanasios J ^a   Branham, Kari ^a   Yashar, Beverly M ^a   Haimann, Mark H ^d   Trzupek, Karmen ^e   Meltzer, Meira ^c   Blain, Delphine ^c,f   Richards, Julia E ^a,b   Weleber, Richard G ^e   Heckenlively, John R ^a   Sieving, Paul A ^a,c   Ayyagari, Radha ^a,g  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c NATIONAL EYE INSTITUTE   (United States)

^d Retina Consultants of Michigan   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f MEDSTAR RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A4; C10 TUMOR NECROSIS FACTOR RELATED PROTEIN 5; ELOVL4 PROTEIN; EPIDERMAL GROWTH FACTOR CONTAINING FIBULINLIKE EXTRACELLULAR MATRIX PROTEIN 1; PERIPHERIN; PROTEIN; RETINOSCHISIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG; VITELLIFORM MACULAR DYSTROPHY 2 PROTEIN;

ADULT; ADULT ONSET BEST DISEASE; ADULT ONSET FOVEOMACULAR DYSTROPHY; ADULT ONSET VITELLIFORM MACULAR GEGENRATION; ARTICLE; BEST MACULAR DEGENERATION; BULLS EYE MACULOPATHY; BUTTERFLY MACULAR DYSTROPHY; DIAGNOSTIC TEST; DOMINANT STARGARDTLIKE MACULAR DEGENERATION; DOYNE HONEYCOMB DYSTROPHY; EYE FUNDUS FLAVIMACULATUS; GENE SEQUENCE; GENETIC COUNSELING; GENETIC DISORDER; HETEROZYGOTE; HUMAN; LABORATORY TEST; LATE ONSET DOMINANT MACULAR DEGENERATION; MALATTIA LEVENTINESE; MALE; MUTATIONAL ANALYSIS; PATIENT EDUCATION; PATTERN DYSTROPHY; PRIORITY JOURNAL; RETINA CONE ROD DYSTROPHY; RETINA DEGENERATION; RETINA DISEASE; RETINITIS PIGMENTOSA; RETINOSCHISIS; SCHOOL CHILD; SORSBY FUNDUS DYSTROPHY; STARGARDT MACULAR DEGENERATION;

ADULT; ATP-BINDING CASSETTE TRANSPORTERS; CHILD; COLLAGEN; DNA MUTATIONAL ANALYSIS; EXTRACELLULAR MATRIX PROTEINS; EYE PROTEINS; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; NERVE TISSUE PROTEINS; PATIENT EDUCATION; RETINAL DEGENERATION; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 33846965253     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.2.252     Document Type: Article

References (53)

1. Heckenlively JR. Retinitis Pigmentosa. Philadelphia, Pa: JB Lippincott Co; 1988.
2. Traboulsi E. Genetic Diseases of the Eye. New York, NY: Oxford University Press Inc; 1998.
3. Iannaccone A. Genotype-phenotype correlations and differential diagnosis in autosomal dominant macular disease. Doc Ophthalmol. 2001;102:197-236.
4. RetNet: retinal information network Web site. http://www.sph.uth.tmc.edu/ Retnet/. Accessed November 11, 2006.
5. Cremers FP, van de Pol DJ, van Driel M, et al. Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease gene ABCR. Hum Mol Genet. 1998;7:355-362.
6. Weleber RG, Carr RE, Murphey WH, Sheffield VC, Stone EM. Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene. Arch Ophthalmol. 1993;111:1531-1542.
7. Kajiwara K, Berson EL, Dryja TP. Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science. 1994;264:1604-1608.
8. Genetests Web site. http://www.genetests.org/. Accessed November 11, 2006.
9. Jaakson K, Zernant J, Kulm M, et al. Genotyping microarray (gene chip) for the ABCR (ABCA4) gene. Hum Mutat. 2003;22:395-403.
10. Stone EM, Lotery AJ, Munier FL, et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet. 1999;22:199-202.
11. Zhang K, Kniazeva M, Han M, et al. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet. 2001;27:89-93.
12. Weber BH, Vogt G, Pruett RC, Stohr H, Felbor U. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet. 1994;8:352-356.
13. Caldwell GM, Kakuk LE, Griesinger IB, et al. Bestrophin gene mutations in patients with Best vitelliform macular dystrophy. Genomics. 1999;58:98-101.
14. Briggs CE, Rucinski D, Rosenfeld PJ, Hirose T, Berson EL, Dryja TP. Mutations in ABCR (ABCA4) in patients with Stargardt macular degeneration or cone-rod degeneration. Invest Ophthalmol Vis Sci. 2001;42:2229-2236.
15. Sauer CG, Gehrig A, Warneke-Wittstock R, et al. Positional cloning of the gene associated with X-linked juvenile retinoschisis. Nat Genet. 1997;17:164-170.
16. Hayward C, Shu X, Cideciyan AV, et al. Mutation in a short-chain collagen gene, CTRP5, results in extracellular deposit formation in late-onset retinal degeneration: a genetic model for age-related macular degeneration. Hum Mol Genet. 2003;12:2657-2667.
17. Khani SC, Karoukis AJ, Young JE, et al. Late-onset autosomal dominant macular dystrophy with choroidal neovascularization and nonexudative maculopathy associated with mutation in the RDS gene. Invest Ophthalmol Vis Sci. 2003;44:3570-3577.
18. Stone EM. Finding and interpreting genetic variations that are important to ophthalmologists. Trans Am Ophthalmol Soc. 2003;101:437-484.
19. Retina International scientific newsletter. http://www.retina- international.org/sci-news/mutation.htm. Accessed November 11, 2006.
20. The human gene mutation database at the Institute of Medical Genetics in Cardiff. http://www.hgmd.cf.ac.uk/ac/index/php. Accessed November 11, 2006.
21. Single nucleotide polymorphism Web site. http://www.ncbi.nlm.nih.gov/SNP/ . Accessed November 11, 2006.
22. ACMG. ACMG recommendations for standards for interpretation of sequence variations. Genet Med. 2000;2(5):302-303.
23. Ayyagari R, Mandal MN, Karoukis AJ, et al. Late-onset macular degeneration and long anterior lens zonules result from a CTRP5 gene mutation. Invest Ophthalmol Vis Sci. 2005;46:3363-3371.
24. Sorsby A MM, Gardener N. A fundus dystrophy with unusual features. Br J Ophthalmol. 1949;1949:67-97.
25. Petrukhin K, Koisti MJ, Bakall B, et al. Identification of the gene responsible for Best macular dystrophy. Nat Genet. 1998;19:241-247.
26. Maugeri A, van Driel MA, van de Pol DJ, et al. The 2588G→C mutation in the ABCR gene is a mild frequent founder mutation in the Western European population and allows the classification of ABCR mutations in patients with Stargardt disease. Am J Hum Genet. 1999;64:1024-1035.
27. Rivera A, White K, Stohr H, et al. A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am J Hum Genet. 2000;67:800-813.
28. Holtzman NA, Murphy PD, Watson MS, Barr PA. Predictive genetic testing: from basic research to clinical practice. Science. 1997;278:602-605.
29. Bergren SK, Chen S, Galecki A, Kearney JA. Genetic modifiers affecting severity of epilepsy caused by mutation of sodium channel Scn2a. Mamm Genome. 2005;16:683-690.
30. Slieker MG, Sanders EA, Rijkers GT, Ruven HJ, van der Ent CK. Disease modifying genes in cystic fibrosis. J Cyst Fibros. 2005;4(suppl 2):7-13.
31. Eriksson M, Brown WT, Gordon LB, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003;423:293-298.
32. McGovern MM, Benach M, Zinberg R. Interaction of genetic counselors with molecular genetic testing laboratories: implications for non-geneticist health care providers. Am J Med Genet A. 2003;119:297-301.
33. Bernhardt BA, Geller G, Strauss M, et al. Toward a model informed consent process for BRCA1 testing: a qualitative assessment of women's attitudes. J Genet Couns. 1997;6:207-222.
34. Walker AP. The practice of genetic counseling. In: Baker DL, Uhlmann WR, eds. A Guide to Genetic Counseling. New York, NY: Wiley-Liss; 1998:1-20.
35. Michie S, Smith JA, Senior V, Marteau TM. Understanding why negative genetic test results sometimes fail to reassure. Am J Med Genet A. 2003;119:340-347.
36. Kay E, Kingston H. Feelings associated with being a carrier and characteristics of reproductive decision making in women known to be carriers of X-linked conditions. J Health Psychol. 2002;7:169-181.
37. Schuette JL, Bennett RL. Lessons in history: obtaining the family history and constructing a pedigree. In: Baker DL, Uhlmann WR, eds. A Guide to Genetic Counseling. New York, NY: Wiley-Liss; 1998:27-51.
38. Baker DL. Interviewing techniques. In: Baker DL, Uhlmann WR, eds. A Guide to Genetic Counseling. New York, NY: Wiley-Liss; 1998:55-73.
39. Uhlmann WR. A guide to case management: coordinating genetic testing. In: Baker DL, Uhlmann WR, eds. A Guide to Genetic Counseling. New York, NY: Wiley-Liss; 1998:211-219.
40. Uhlmann WR. A guide to case management: communicating results. In: Baker DL, Uhlmann WR, eds. A Guide to Genetic Counseling. New York, NY: Wiley-Liss; 1998:225-226.
41. Uhlmann WR. A guide to case management: communicating with other specialists and researchers. In: Baker DL, Uhlmann WR, eds. A Guide to Genetic Counseling. New York, NY: Wiley-Liss; 1998:226-227.
42. Ward PA. New and evolving technologies: implementation considerations for genetic counselors. In: Baker DL, Uhlmann WR, eds. A Guide to Genetic Counseling. New York, NY: Wiley-Liss; 1998:347-369.
43. Klevering BJ, Yzer S, Rohrschneider K, et al. Microarray-based mutation analysis of the ABCA4 (ABCR) gene in autosomal recessive cone-rod dystrophy and retinitis pigmentosa. Eur J Hum Genet. 2004;12:1024-1032.
44. Zernant J, Kulm M, Dharmaraj S, et al. Genotyping microarray (disease chip) for Leber congenital amaurosis: detection of modifier alleles. Invest Ophthalmol Vis Sci. 2005;46:3052-3059.
45. Mandal MN, Heckenlively JR, Burch T, et al. Sequencing arrays for screening multiple genes associated with early-onset human retinal degenerations on a high-throughput platform. Invest Ophthalmol Vis Sci. 2005;46:3355-3362.
46. Girardet A, Hamamah S, Anahory T, et al. First preimplantation genetic diagnosis of hereditary retinoblastoma using informative microsatellite markers. Mol Hum Reprod. 2003;9:111-116.
47. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet. 2001;28:92-95.
48. Radu RA, Mata NL, Nusinowitz S, Liu X, Sieving PA, Travis GH. Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration. Proc Natl Acad Sci U S A. 2003;100:4742-4747.
49. Dinculescu A, Glushakova L, Min SH, Hauswirth WW. Adeno-associated virus-vectored gene therapy for retinal disease. Hum Gene Ther. 2005;16:649-663.
50. Kiang AS, Palfi A, Ader M, et al. Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approach. Mol Ther. 2005;12:555-561.
51. Preising MN, Heegard S. Recent advances in early-onset severe retinal degeneration: more than just basic research. Trends Mol Med. 2004;10:51-54.
52. Ali RR. Prospects for gene therapy. Novartis Found Symp. 2004;255:165-178.
53. Pawlyk BS, Smith AJ, Buch PK, et al. Gene replacement therapy rescues photoreceptor degeneration in a murine model of Leber congenital amaurosis lacking RPGRIP. Invest Ophthalmol Vis Sci. 2005;46:3039-3045.